Bamlanivimab and Etesevimab Injection

Name: Negotiated commercial rates for Bamlanivimab and Etesevimab Injection (HCPCS Q0245), in New Hampshire
Creator: Tynbil
License: https://tynbil.com/terms

New Hampshire rates for HCPCS Q0245

Injection, bamlanivimab and etesevimab, 2100 mg

Rates data updated July 2026.

Rates by insurance carrier

Insurance Carrier	Facility/Professional	Modifier	Typical Low	Median	Typical High